Budoprutug receives FDA Fast Track status for primary membranous nephropathy after phase 1b data demonstrate clinical activity and safety.

The FDA has granted Fast Track designation to the investigational antibody-drug conjugate (ADC) SIM0505 for the treatment of women with platinum-resistant ovarian cancer. The designation adds SIM0505 ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SIM0505 for the treatment of women with platinum resistant ovarian cancer (PROC) Phase 1 data for SIM0505 to be ...

Trump’s proposed FY2027 budget boosts Lockheed’s AIM-260 missile funding to $2.9B, hinting at faster production and ...

The WNBA and its players’ union agreed to start free agency on Monday, the league announced Sunday. Teams will have two days ...

This adrenaline-packed Arizona go-kart track offers the kind of fast, competitive action that makes you feel like you are in ...

Australia's Fortescue said ‌on Friday it was expediting the rollout of an off-grid green energy system to eliminate fossil ...

Furious debate has erupted among Queenslanders after Premier David Crisafulli called on the Commonwealth to grant a “national ...

The Union Cabinet is learnt to have cleared on Wednesday draft bills which seek to implement the Women's Reservation Act ...

N.J. girls track and field is back and the return to action has been a terrific watch. On both the oval and grass, this ...

House Bill 334 was introduced by Rep. Omari Crawford (D‑Decatur) and attracted a slate of Democratic cosponsors, according to ...

Below, take a look at the season’s first edition of the N.J. girls track and field notebook, which includes the meets to ...